nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.448	1	CbGbCtD
Norepinephrine—POU5F1—cerebellum—amyotrophic lateral sclerosis	0.0206	0.106	CbGeAlD
Norepinephrine—SLC18A1—nervous system—amyotrophic lateral sclerosis	0.0081	0.0417	CbGeAlD
Norepinephrine—SLC22A3—tongue—amyotrophic lateral sclerosis	0.008	0.0413	CbGeAlD
Norepinephrine—SLC18A1—central nervous system—amyotrophic lateral sclerosis	0.0078	0.0402	CbGeAlD
Norepinephrine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00702	0.0362	CbGeAlD
Norepinephrine—DRD2—nerve—amyotrophic lateral sclerosis	0.0064	0.033	CbGeAlD
Norepinephrine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00636	0.0328	CbGeAlD
Norepinephrine—SLC18A1—brain—amyotrophic lateral sclerosis	0.00619	0.0319	CbGeAlD
Norepinephrine—PAH—nervous system—amyotrophic lateral sclerosis	0.00581	0.03	CbGeAlD
Norepinephrine—PAH—central nervous system—amyotrophic lateral sclerosis	0.00559	0.0288	CbGeAlD
Norepinephrine—SLC18A2—brainstem—amyotrophic lateral sclerosis	0.00494	0.0255	CbGeAlD
Norepinephrine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00489	0.0252	CbGeAlD
Norepinephrine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00479	0.0247	CbGeAlD
Norepinephrine—PAH—brain—amyotrophic lateral sclerosis	0.00444	0.0229	CbGeAlD
Norepinephrine—SLC22A3—embryo—amyotrophic lateral sclerosis	0.00384	0.0198	CbGeAlD
Norepinephrine—SLC18A2—medulla oblongata—amyotrophic lateral sclerosis	0.00344	0.0177	CbGeAlD
Norepinephrine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00301	0.0155	CbGeAlD
Norepinephrine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.0028	0.0144	CbGeAlD
Norepinephrine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00275	0.0142	CbGeAlD
Norepinephrine—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00261	0.0135	CbGeAlD
Norepinephrine—SLC18A2—nervous system—amyotrophic lateral sclerosis	0.00259	0.0133	CbGeAlD
Norepinephrine—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.00256	0.0132	CbGeAlD
Norepinephrine—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00251	0.013	CbGeAlD
Norepinephrine—SLC18A2—central nervous system—amyotrophic lateral sclerosis	0.00249	0.0128	CbGeAlD
Norepinephrine—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.00246	0.0127	CbGeAlD
Norepinephrine—SLC18A2—cerebellum—amyotrophic lateral sclerosis	0.00243	0.0125	CbGeAlD
Norepinephrine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.0021	0.0108	CbGeAlD
Norepinephrine—ADRA1B—brain—amyotrophic lateral sclerosis	0.002	0.0103	CbGeAlD
Norepinephrine—SLC18A2—brain—amyotrophic lateral sclerosis	0.00198	0.0102	CbGeAlD
Norepinephrine—ADRA1D—brain—amyotrophic lateral sclerosis	0.00195	0.0101	CbGeAlD
Norepinephrine—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.00193	0.00994	CbGeAlD
Norepinephrine—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00186	0.0096	CbGeAlD
Norepinephrine—ADRB1—nervous system—amyotrophic lateral sclerosis	0.00186	0.00957	CbGeAlD
Norepinephrine—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.00186	0.00957	CbGeAlD
Norepinephrine—SLC22A3—nervous system—amyotrophic lateral sclerosis	0.00184	0.0095	CbGeAlD
Norepinephrine—ADRB1—central nervous system—amyotrophic lateral sclerosis	0.00179	0.00921	CbGeAlD
Norepinephrine—SLC22A5—medulla oblongata—amyotrophic lateral sclerosis	0.00178	0.00919	CbGeAlD
Norepinephrine—SLC22A3—central nervous system—amyotrophic lateral sclerosis	0.00177	0.00914	CbGeAlD
Norepinephrine—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00166	0.00856	CbGeAlD
Norepinephrine—SLC22A5—spinal cord—amyotrophic lateral sclerosis	0.00159	0.0082	CbGeAlD
Norepinephrine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.00158	0.00814	CbGeAlD
Norepinephrine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.00152	0.00784	CbGeAlD
Norepinephrine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00149	0.00766	CbGeAlD
Norepinephrine—SLC22A1—brain—amyotrophic lateral sclerosis	0.00147	0.0076	CbGeAlD
Norepinephrine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00147	0.00757	CbGeAlD
Norepinephrine—DRD2—nervous system—amyotrophic lateral sclerosis	0.00144	0.00742	CbGeAlD
Norepinephrine—ADRB1—brain—amyotrophic lateral sclerosis	0.00142	0.00731	CbGeAlD
Norepinephrine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00141	0.00728	CbGeAlD
Norepinephrine—SLC22A3—brain—amyotrophic lateral sclerosis	0.00141	0.00726	CbGeAlD
Norepinephrine—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.0014	0.00721	CbGeAlD
Norepinephrine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00138	0.00714	CbGeAlD
Norepinephrine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00138	0.00712	CbGeAlD
Norepinephrine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00135	0.00698	CbGeAlD
Norepinephrine—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.00135	0.00694	CbGeAlD
Norepinephrine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00132	0.00683	CbGeAlD
Norepinephrine—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.00132	0.00678	CbGeAlD
Norepinephrine—SLC22A5—cerebellum—amyotrophic lateral sclerosis	0.00126	0.0065	CbGeAlD
Norepinephrine—SLC6A2—brain—amyotrophic lateral sclerosis	0.00121	0.00622	CbGeAlD
Norepinephrine—ADRA1A—brain—amyotrophic lateral sclerosis	0.00112	0.00578	CbGeAlD
Norepinephrine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00112	0.00575	CbGeAlD
Norepinephrine—DRD2—brain—amyotrophic lateral sclerosis	0.0011	0.00567	CbGeAlD
Norepinephrine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.00107	0.00554	CbGeAlD
Norepinephrine—ADRA2C—brain—amyotrophic lateral sclerosis	0.00107	0.00551	CbGeAlD
Norepinephrine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00105	0.00541	CbGeAlD
Norepinephrine—SLC22A5—brain—amyotrophic lateral sclerosis	0.00102	0.00528	CbGeAlD
Norepinephrine—ADRA2A—brain—amyotrophic lateral sclerosis	0.000853	0.0044	CbGeAlD
Norepinephrine—DRD2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000114	0.000318	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000113	0.000316	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000113	0.000314	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000113	0.000314	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000112	0.000312	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000111	0.000309	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00011	0.000306	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.00011	0.000306	CbGpPWpGaD
Norepinephrine—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000109	0.000305	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000109	0.000304	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000108	0.000303	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000108	0.000302	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000107	0.0003	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000107	0.000299	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000106	0.000297	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000106	0.000297	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000105	0.000293	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000105	0.000293	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000104	0.000292	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000104	0.000291	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000104	0.000291	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000103	0.000289	CbGpPWpGaD
Norepinephrine—PAH—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000103	0.000288	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000103	0.000288	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—GSR—amyotrophic lateral sclerosis	0.000103	0.000288	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000103	0.000287	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000102	0.000286	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000102	0.000285	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000102	0.000285	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000101	0.000282	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000101	0.000281	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.99e-05	0.000279	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	9.93e-05	0.000277	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	9.81e-05	0.000274	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	9.77e-05	0.000273	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.73e-05	0.000272	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.57e-05	0.000267	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	9.52e-05	0.000266	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	9.45e-05	0.000264	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	9.43e-05	0.000264	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	9.41e-05	0.000263	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	9.34e-05	0.000261	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	9.33e-05	0.000261	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	9.31e-05	0.00026	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	9.3e-05	0.00026	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—IGF1—amyotrophic lateral sclerosis	9.24e-05	0.000258	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	9.21e-05	0.000257	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.18e-05	0.000256	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	9.01e-05	0.000252	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	9e-05	0.000251	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	8.96e-05	0.00025	CbGpPWpGaD
Norepinephrine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	8.88e-05	0.000248	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8.81e-05	0.000246	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	8.78e-05	0.000245	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	8.71e-05	0.000243	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	8.68e-05	0.000242	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8.67e-05	0.000242	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	8.64e-05	0.000241	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—IGF1—amyotrophic lateral sclerosis	8.63e-05	0.000241	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	8.58e-05	0.00024	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CHAT—amyotrophic lateral sclerosis	8.46e-05	0.000236	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.44e-05	0.000236	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	8.41e-05	0.000235	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.33e-05	0.000233	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	8.32e-05	0.000233	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	8.14e-05	0.000227	CbGpPWpGaD
Norepinephrine—DRD2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	8.09e-05	0.000226	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	8.06e-05	0.000225	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8e-05	0.000223	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.91e-05	0.000221	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.87e-05	0.00022	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.83e-05	0.000219	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.8e-05	0.000218	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.7e-05	0.000215	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.7e-05	0.000215	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	7.66e-05	0.000214	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—C3—amyotrophic lateral sclerosis	7.63e-05	0.000213	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.62e-05	0.000213	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	7.59e-05	0.000212	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	7.49e-05	0.000209	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.29e-05	0.000203	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.17e-05	0.0002	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.16e-05	0.0002	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.1e-05	0.000198	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	7.09e-05	0.000198	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.08e-05	0.000198	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	7.01e-05	0.000196	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.98e-05	0.000195	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.96e-05	0.000194	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—APOE—amyotrophic lateral sclerosis	6.94e-05	0.000194	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.92e-05	0.000193	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.89e-05	0.000193	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.8e-05	0.00019	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.66e-05	0.000186	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.61e-05	0.000185	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.47e-05	0.000181	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.45e-05	0.00018	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.44e-05	0.00018	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.43e-05	0.00018	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.41e-05	0.000179	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.37e-05	0.000178	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.34e-05	0.000177	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.34e-05	0.000177	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.33e-05	0.000177	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.2e-05	0.000173	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	6.17e-05	0.000172	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.07e-05	0.000169	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	6.04e-05	0.000169	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.01e-05	0.000168	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.99e-05	0.000167	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.93e-05	0.000166	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.92e-05	0.000165	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.89e-05	0.000165	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.84e-05	0.000163	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.78e-05	0.000161	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.76e-05	0.000161	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.76e-05	0.000161	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.73e-05	0.00016	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	5.69e-05	0.000159	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.65e-05	0.000158	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	5.64e-05	0.000157	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.63e-05	0.000157	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.62e-05	0.000157	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.6e-05	0.000156	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.53e-05	0.000154	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.43e-05	0.000152	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.43e-05	0.000152	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.37e-05	0.00015	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.35e-05	0.000149	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.33e-05	0.000149	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.29e-05	0.000148	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.26e-05	0.000147	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.23e-05	0.000146	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.23e-05	0.000146	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.18e-05	0.000145	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.15e-05	0.000144	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.1e-05	0.000143	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.09e-05	0.000142	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.95e-05	0.000138	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.93e-05	0.000138	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.91e-05	0.000137	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.9e-05	0.000137	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.86e-05	0.000136	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.85e-05	0.000136	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.84e-05	0.000135	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.76e-05	0.000133	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.68e-05	0.000131	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.67e-05	0.000131	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.65e-05	0.00013	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.61e-05	0.000129	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	4.58e-05	0.000128	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.58e-05	0.000128	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.56e-05	0.000127	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	4.56e-05	0.000127	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.55e-05	0.000127	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.55e-05	0.000127	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.51e-05	0.000126	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.51e-05	0.000126	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	4.35e-05	0.000122	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.34e-05	0.000121	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.3e-05	0.00012	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.26e-05	0.000119	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	4.26e-05	0.000119	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.24e-05	0.000118	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	4.23e-05	0.000118	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.2e-05	0.000117	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.18e-05	0.000117	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.15e-05	0.000116	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.11e-05	0.000115	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.1e-05	0.000115	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.07e-05	0.000114	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	4.06e-05	0.000113	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.02e-05	0.000112	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4e-05	0.000112	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.91e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.87e-05	0.000108	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.83e-05	0.000107	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.8e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.79e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.76e-05	0.000105	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.74e-05	0.000105	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.74e-05	0.000105	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.72e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.54e-05	9.89e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.5e-05	9.76e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.48e-05	9.73e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.48e-05	9.72e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.47e-05	9.69e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	3.46e-05	9.66e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.45e-05	9.64e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	3.44e-05	9.61e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.33e-05	9.29e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.21e-05	8.97e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.16e-05	8.83e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.13e-05	8.75e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.1e-05	8.65e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.09e-05	8.64e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.09e-05	8.63e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.98e-05	8.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.93e-05	8.17e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.92e-05	8.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.9e-05	8.1e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.88e-05	8.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.88e-05	8.03e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.78e-05	7.77e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.67e-05	7.46e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.65e-05	7.42e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.63e-05	7.34e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.56e-05	7.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.52e-05	7.05e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.51e-05	7.01e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.43e-05	6.8e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.41e-05	6.73e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.38e-05	6.65e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.38e-05	6.64e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.36e-05	6.58e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.31e-05	6.45e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.3e-05	6.42e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.28e-05	6.36e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.27e-05	6.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.25e-05	6.29e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.25e-05	6.28e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.22e-05	6.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.13e-05	5.94e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.09e-05	5.85e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.06e-05	5.77e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.05e-05	5.71e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.04e-05	5.71e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.02e-05	5.64e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.97e-05	5.5e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.93e-05	5.39e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.91e-05	5.34e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.9e-05	5.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.88e-05	5.25e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.86e-05	5.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.83e-05	5.11e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.73e-05	4.84e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.73e-05	4.83e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.71e-05	4.78e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.67e-05	4.67e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.56e-05	4.36e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.55e-05	4.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.55e-05	4.32e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.53e-05	4.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.44e-05	4.03e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.42e-05	3.97e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.31e-05	3.66e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.3e-05	3.63e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.26e-05	3.53e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.17e-05	3.28e-05	CbGpPWpGaD
